Share this page

Twitter Facebook
The Global Fund / John Rae

The Global Fund Strategy is a multi-year road map for our partnership’s future. The strategy sets out priorities for how our partnership can accelerate progress against HIV, TB and malaria and improve global health. It also includes ambitious goals and targets to measure progress.

The Global Fund Strategy 2017-2022

The Global Fund Strategy 2017-2022: Investing to End Epidemics outlines our partnership’s bold agenda for 2017-2022 based on an ambitious vision to end the epidemics. These four strategic objectives are at the core of the strategy:

Each strategic objective is each underpinned by a number of sub-objectives and supported by two strategic enablers. These objectives provide a critical path outlining how the Global Fund will work with partners to ensure that the response globally and at country level is inclusive, impactful and sustainable. Progress on implementation of our strategy is measured through key performance indicators and undertaken at all levels of the Global Fund partnership.

Download the full Global Fund Strategy 2017-2022 for a detailed look at our objectives and key performance indicators as well as how the strategy links to achievement of the Sustainable Development Goals.

The Global Fund Strategy 2017-2022: Investing to End Epidemics
download in English | Français


The strategy’s performance targets call for programs supported by the Global Fund to save 14 million lives in the three-year period beginning in 2017, bringing the total lives saved by the Global Fund partnership to 36 million by the end of 2019. Those programs will also avert up to 194 million new infections or cases of HIV, TB and malaria. Global Fund support will further catalyze US$35 billion in domestic finance for health and drive US$230 billion in economic gains.

Projections show that every US$100 million invested in Global Fund-supported programs will:

  • Save 133,000 lives through programs supported by the Global Fund, and;
  • Avert 1.9 million new infections or cases across the three diseases, and;
  • Spur domestic investment of US$300 million toward the three diseases, and;
  • Create US$2.2 billion in long-term economic gains, and;
  • Provide antiretroviral therapy for 107,000 people, and;
  • Provide treatment for 31,000 women to prevent passing HIV to their babies, and;
  • Provide TB treatment and care for 153,000 people, and;
  • Provide 4,300 people with treatment for multidrug-resistant TB, and;
  • Distribute 6.2 million mosquito nets to protect children and families from malaria, and;
  • Provide indoor residual spraying for 1.2 million households to protect children and families from malaria.


The Global Fund Partnership Forum gives all partners a special venue for contributing critical input, suggestions and views about the development of the Global Fund Strategy. With this substantive guidance and input from a broad range of stakeholders, the Global Fund Strategy is then developed. The Partnership Forum forms part of our governance structure.

Partnership Forum 2015

The Global Fund Strategy 2017-2022 was developed through an extensive consultation process in 2014-2015 that collected the strongest ideas, perspective and guidance. The consultations included three regional Partnership Forums with over 300 participants from 128 countries, a 12-week online consultation with over 1,200 participants from 143 countries, and dozens of focused meetings and consultations on specific aspects of the strategy. The strategy development process captured the expertise, diversity and innovative spirit of the Global Fund Board, and integrated broader views and experience of partners.

Themes that emerged from the consultations included the need to better address challenges faced by women and girls; the need to support resilient and sustainable systems for health; and the need to strengthen work on sustainability and human rights.

The recommendations that came out of these consultations were submitted to the Board, which unanimously approved the strategy in April 2016. The Board approved the performance targets in March 2017.

Published 23 October 2018